Van Leeuwen & Company, LLC Abbott Laboratories Transaction History

Van Leeuwen & Company, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $5.76 Million - $6.79 Million	-52,928 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $420 - $457	-4 Reduced 0.01%	52,928 $5.8 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $1.72 Million - $2.09 Million	18,814 Added 55.14%	52,932 $5.76 Million
Q2 2020 Aug 03, 2020	SELL	$76.57 - $98.0 $1.35 Million - $1.73 Million	-17,630 Reduced 34.07%	34,118 $3.12 Million
Q1 2020 Apr 23, 2020	SELL	$62.82 - $91.86 $228,413 - $334,002	-3,636 Reduced 6.57%	51,748 $4.08 Million
Q4 2019 Feb 04, 2020	SELL	$78.51 - $87.4 $9,578 - $10,662	-122 Reduced 0.22%	55,384 $4.81 Million
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $63,180 - $68,507	-772 Reduced 1.37%	55,506 $4.64 Million
Q2 2019 Jul 31, 2019	SELL	$72.88 - $85.0 $190,945 - $222,700	-2,620 Reduced 4.45%	56,278 $4.73 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $94,959 - $114,806	-1,434 Reduced 2.38%	58,898 $4.71 Million
Q4 2018 Mar 13, 2019	BUY	$65.56 - $74.27 $1.49 Million - $1.69 Million	22,791 Added 60.71%	60,332 $4.36 Million
Q3 2018 Mar 13, 2019	BUY	$60.81 - $73.36 $2.28 Million - $2.75 Million	37,541 New	37,541 $2.75 Million

3,187

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Van Leeuwen & Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Van Leeuwen & Company, LLC with notifications on news.